RxDoctor Payments Data

David Beatty, MD

Pain Medicine · Elkhart, INNPI 1174534895

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 75.4% of it on its own, with 6 other manufacturers making up the rest.

$4,494in general payments, 2019–2025

Across 125 payments — averaging $35.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Globus Medical$460
  • Nevro Corp.$191
  • Boston Scientific$163
  • Vertos Medical, Inc.$133
  • Abbott$125
  • plus $33 from 1 others

What the payments were for

  • Food & beverage$4,494100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,494 in reported general payments places this provider in the 55th percentile of 128 pain medicine providers in Indiana.

See all pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$157,379
Medicare patients
453
Services billed
2,214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl56$47,183
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,050$27,666
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,207$26,948
Fentanyl127$14,114
SavellaMilnacipran Hcl21$11,803
Xtampza ErOxycodone Myristate11$10,490
Oxycodone Hcl405$9,975
Gabapentin710$9,864
Pregabalin186$6,009
Morphine Sulfate ErMorphine Sulfate185$5,137
Lidocaine47$4,920
ValiumDiazepam11$3,755
Tizanidine Hcl379$3,341
Tramadol Hcl370$3,170
Methadone Hcl133$2,868

Paid to pharmacies, not to this prescriber.

Other pain medicine in Elkhart

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →